Ellsworth Advisors LLC Acquires Shares of 11,984 iRadimed Corporation $IRMD

Key Points

• Ellsworth Advisors LLC acquired 11,984 shares of iRadimed Corporation (NASDAQ:IRMD), valued at approximately $629,000, as indicated in its recent SEC filing.
• iRadimed's stock experienced a 3.8% increase, hitting $74.27, and the company announced a quarterly dividend of $0.17 per share, equating to a yield of 0.9%.
• Institutional investors and hedge funds own 92.34% of iRadimed's stock, with notable stakes and increases from several other firms in the first quarter.

Ellsworth Advisors LLC bought a new stake in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,984 shares of the medical equipment provider's stock, valued at approximately $629,000. Ellsworth Advisors LLC owned approximately 0.09% of iRadimed as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. First Horizon Advisors Inc. lifted its stake in shares of iRadimed by 78.7% during the 1st quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock valued at $27,000 after buying an additional 226 shares in the last quarter. US Bancorp DE lifted its stake in shares of iRadimed by 132.7% during the 1st quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock valued at $75,000 after buying an additional 819 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of iRadimed during the 1st quarter valued at $78,000. Comerica Bank lifted its stake in shares of iRadimed by 21.4% during the 1st quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock valued at $120,000 after buying an additional 404 shares in the last quarter. Finally, State of Wyoming purchased a new position in shares of iRadimed during the 4th quarter valued at $149,000. Hedge funds and other institutional investors own 92.34% of the company's stock.

iRadimed Stock Up 0.5%

NASDAQ IRMD traded up $0.34 on Monday, reaching $71.61. The company had a trading volume of 39,081 shares, compared to its average volume of 44,428. The stock has a market capitalization of $910.52 million, a PE ratio of 44.20 and a beta of 1.02. The firm's 50 day moving average price is $66.07 and its 200 day moving average price is $58.51. iRadimed Corporation has a 12 month low of $46.86 and a 12 month high of $74.43.

iRadimed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a yield of 0.9%. iRadimed's dividend payout ratio is presently 41.98%.

Insider Buying and Selling

In other iRadimed news, Director Monty K. Allen sold 1,102 shares of iRadimed stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total value of $76,148.20. Following the sale, the director owned 19,898 shares of the company's stock, valued at $1,374,951.80. The trade was a 5.25% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 36.80% of the company's stock.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.